PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery

Description

This study seeks to understand how frailty, a term that describes people who are more vulnerable stressors such as a new medical problem, affects the outcomes and quality of life in adult patients with gynecologic cancer.

Conditions

Malignant Female Reproductive System Neoplasm, Gynecologic Cancer, Gynecologic Neoplasm

Study Overview

Study Details

Study overview

This study seeks to understand how frailty, a term that describes people who are more vulnerable stressors such as a new medical problem, affects the outcomes and quality of life in adult patients with gynecologic cancer.

PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery - PROOF Prospective Cohort Study

PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery

Condition
Malignant Female Reproductive System Neoplasm
Intervention / Treatment

-

Contacts and Locations

San Francisco

University of California, San Francisco, San Francisco, California, United States, 94143

Boston

Dana Farber Cancer Institute, Boston, Massachusetts, United States, 02215

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 18 years or greater
  • * Undergoing evaluation for a newly diagnosed gynecologic malignancy
  • * Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it
  • * Contraindication to any study-related procedure or assessment
  • * Does not speak a language for which the consent form and study materials are available

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Francisco,

Stephanie Cham, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

2033-11-30